Crossmark

Siamese neural networks for continuous disease severity evaluation and change detection in medical imaging

Crossref DOI link: https://doi.org/10.1038/s41746-020-0255-1

Published Online: 2020-03-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Matthew D. https://orcid.org/0000-0002-6207-4940
Chang, Ken

Bearce, Ben

Chang, Connie Y.

Huang, Ambrose J.

Campbell, J. Peter https://orcid.org/0000-0001-7964-9475
Brown, James M. https://orcid.org/0000-0001-7636-4554
Singh, Praveer

Hoebel, Katharina V.

Erdoğmuş, Deniz

Ioannidis, Stratis

Palmer, William E.

Chiang, Michael F. https://orcid.org/0000-0002-8172-7636
Kalpathy-Cramer, Jayashree https://orcid.org/0000-0001-8906-9618
Funding

Funding for this research was provided by:

National Science Foundation (SCH-1622542, SCH-1622679)

U.S. Department of Health & Human Services | National Institutes of Health (U01 CA154601, U24 CA180927, U24 CA180918, P41EB015896, K12EY027720, R01EY019474, K12EY027720, P30EY10572)

U.S. Department of Health & Human Services | National Institutes of Health

U.S. Department of Health & Human Services | National Institutes of Health

U.S. Department of Health & Human Services | National Institutes of Health

U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (5T32EB1680)

U.S. Department of Health & Human Services | NIH | National Cancer Institute (F30CA239407)

U.S. Department of Health & Human Services | National Institutes of Health

U.S. Department of Health & Human Services | National Institutes of Health

U.S. Department of Health & Human Services | National Institutes of Health

U.S. Department of Health & Human Services | National Institutes of Health
License Information

Text and Data Mining valid from 2020-03-26

Version of Record valid from 2020-03-26
More Information

Article History

Received: 21 July 2019

Accepted: 6 March 2020

First Online: 26 March 2020

Competing interests

: The M.F.C is an unpaid member of the scientific advisory board for Clarity Medical Systems (Pleasanton, CA), a consultant for Novartis (Basel, Switzerland), and an initial member of Inteleretina, LLC (Honolulu, HI). J.P.C. and M.F.C. receive research support from Genentech. J.K. is a consultant/advisory board member for Infotech, Soft. The other authors declare no competing interests.

Document is current

Any future updates will be listed below